In the last trading session, 1,673,380 shares of the Anavex Life Sciences Corp.(NASDAQ:AVXL) were traded, and its beta was 0.85. Most recently the company’s share price was $12.89, and it changed around $0.35 or 0.03% from the last close, which brings the market valuation of the company to $895.7 Million. AVXL currently trades at a discount to its 52-week high of $28.7, offering almost -122.65% off that amount. The share price’s 52-week low was $2.2, which indicates that the current value has risen by an impressive 82.93% since then. We note from Anavex Life Sciences Corp.’s average daily trading volume that its 10-day average is 1.63 Million shares, with the 3-month average coming to 3.92 Million.
Anavex Life Sciences Corp. stock received a consensus recommendation rating of Buy, based on a mean score of 1.7. If we narrow it down even further, the data shows that none out of 4 analysts rate the stock as a Sell; another but none rate it as Overweight. Among the rest, no body recommended AVXL as a Hold, whereas 4 deemed it a Buy, and no one rated it as Underweight. Anavex Life Sciences Corp. is expected to report earnings per share of -$0.12 for the current quarter.
Anavex Life Sciences Corp. (NASDAQ:AVXL): Trading Information
Instantly AVXL has showed a green trend with a performance of 2.79% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of $13.67 on Tuesday, Feb 16 increased the stock’s daily price by 5.71%. The company’s shares are currently up 1.39% year-to-date, but still down -0.0242 over the last five days. On the other hand, Anavex Life Sciences Corp. (NASDAQ:AVXL) is 1.11% up in the 30-day period. We can see from the shorts that 5.26 Million shares have been sold at a short interest cover period of 1.34 day(s).
The consensus price target as assigned by Wall Street analysts is $16.5, which translates to bears needing to increase their stock price by 28.01% from its current value. Analyst projections state that AVXL is forecast to be at a low of $10 and a high of $20. In order for the stock price to hit the forecast high, the stock would need to surge +55.16% from its current level, while the stock would need to crash -22.42% from its current level to reach the projected low.
Anavex Life Sciences Corp. (AVXL) projections and forecasts
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 7.1%. Anavex Life Sciences Corp. earnings are expected to increase by 16% in 2021, but the outlook is negative 0% per year for the next five years.
Anavex Life Sciences Corp. (NASDAQ:AVXL)’s Biggest Investors
Upon looking at major shareholders, it appears that insiders hold 3.63% of Anavex Life Sciences Corp. shares, and 19.19% of them are in the hands of institutional investors. The stock currently has a share float of 19.91%. Anavex Life Sciences Corp. stock is held by 103 institutions, with Blackrock Inc. being the largest institutional investor. By Dec 30, 2020, it held 5.29% of the shares, which is about 3.68 Million shares worth $19.87 Million.
Vanguard Group, Inc. (The), with 4.17% or 2.9 Million shares worth $15.64 Million as of Dec 30, 2020, holds the second largest percentage of outstanding shares.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF were the top two Mutual Funds as of Sep 29, 2020. The former held 1721200 shares worth $7.83 Million, making up 2.48% of all outstanding shares. On the other hand, iShares Russell 2000 ETF held roughly 1.25 Million shares worth around $6.73 Million, which represents about 1.79% of the total shares outstanding.